ARCT FY 2023 Earnings — Arcturus Therapeutics Holdings Inc. Revenue & Financial Results | Market Cap Arena

ARCTArcturus Therapeutics Holdings Inc.

$217M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$158M-23.3% YoY

Gross Profit

$158M100.0% margin

Operating Income

-$78M-49.6% margin

Net Income

-$30M-18.8% margin

EPS (Diluted)

$-1.12

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$21M

Stock-Based Comp.

$35M

Balance Sheet

Total Assets

$429M

Total Liabilities

$151M

Stockholders' Equity

$279M

Cash & Equivalents

$292M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$158M	$206M	-23.3%
Gross Profit	$158M	$206M	-23.3%
Operating Income	-$78M	$12M	-742.2%
Net Income	-$30M	$9M	-417.9%